| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/05/1993 | EP0540421A1 Indigestible dextrin |
| 05/05/1993 | EP0540356A2 Process for the preparation of certain substituted biphenyl tetrazoles and compounds thereof |
| 05/05/1993 | EP0540318A1 2-Heterocyclicethylamine derivatives and their use as pharmaceuticals |
| 05/05/1993 | EP0540209A1 Imidazole derivatives and pharmaceutical compositions containing the same |
| 05/05/1993 | EP0540165A1 Alkanoic acid derivatives |
| 05/05/1993 | EP0539848A1 N-(mercaptoacyl)amino acids, methods of their preparation and therapeutic use, and pharmaceutical compositions containing them |
| 05/05/1993 | EP0539806A1 Thiadiazinones and medicines containing them, having in particular a positive inotropic and vasodilating activity |
| 05/05/1993 | EP0539713A1 Substituted imidazolylpropene acid derivatives as angiotensin II inhibitors |
| 05/05/1993 | EP0539509A1 4-alkylimidazole derivatives. |
| 05/05/1993 | CN1071666A Tetrahydroberberine type quaternary ammonium componnd and preparing process |
| 05/05/1993 | CN1020458C Conjugates of superoxide dismutase couples tod high molecular weight polyalkylene glycols |
| 05/04/1993 | US5208324 Paramagnetic compounds |
| 05/04/1993 | US5208256 Treatment of ocular hypertension with a synergistic combination for ocular administration |
| 05/04/1993 | US5208255 Thioester enantiomeric compounds and their therapeutic uses |
| 05/04/1993 | US5208247 Pyridinium compounds which are useful as antagonists of platelet activating factor |
| 05/04/1993 | US5208246 Tetralones with pharmacological activity |
| 05/04/1993 | US5208245 Hypotensive agents |
| 05/04/1993 | US5208243 Analgesics |
| 05/04/1993 | US5208240 8-substituted purines as selective adenosine receptor agents |
| 05/04/1993 | US5208019 Cardiovascular disorders |
| 05/04/1993 | CA1317296C Cardioprotective agent and a therapeutic agent for ischemic disease comprising n-containing heterocyclic compounds, and a process for the preparation of the same compounds |
| 05/04/1993 | CA1317228C Pharmaceutical preparation containing b-blocker and a potassium channel activator |
| 05/04/1993 | CA1317225C Use of adenosine, hypoxanthine and ribose-containing solution for improved protection of the heart during surgery |
| 05/02/1993 | CA2081847A1 Process for the preparation of certain substituted biphenyl tetrazoles and compounds thereof |
| 05/01/1993 | CA2081674A1 Heterocyclic compounds |
| 04/30/1993 | WO1993009087A1 Ethynyl alanine amino diol compounds for treatment of hypertension |
| 04/30/1993 | CA2115847A1 Ethynyl alanine amino diol compounds for treatment of hypertension |
| 04/29/1993 | WO1993008193A1 Imidazole derivatives and pharmaceutical compositions containing the same |
| 04/29/1993 | WO1993008188A1 Tricyclic quinoxalinediones as glutamate receptor antagonists |
| 04/29/1993 | WO1993008187A1 Imidazopyridines and indolizines as 5-ht4 antagonists |
| 04/29/1993 | WO1993008173A1 Quinoxaline derivates with affinity for quisqualate-receptors |
| 04/29/1993 | WO1993008171A1 Pyrimidocycloalkanes as angiotensin ii antagonists |
| 04/29/1993 | WO1993008170A1 Substituted heterocycles as angiotensin ii antagonists |
| 04/29/1993 | WO1993008169A1 Substituted aminopyrimidines as angiotensine ii antagonists |
| 04/29/1993 | WO1993008162A1 N-(mercaptoacyl)amino acids, methods of their preparation and therapeutic use, and pharmaceutical compositions containing them |
| 04/29/1993 | WO1993008155A1 Lignan analog, production thereof, and hypolipidemic drug |
| 04/29/1993 | WO1993007889A1 Synthesis of human procollagens and collagens in recombinant dna systems |
| 04/29/1993 | WO1993007875A1 Use of prostacyclin derivatives to prevent or treat disorders of the microcirculating system when x-ray, nmr or ultrasonic contrasting agents are administered |
| 04/29/1993 | WO1993007856A1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES |
| 04/29/1993 | CA2121838A1 Use of prostacyclin derivatives to prevent or treat disorders of the microcirculating system when x-ray, nmr or ultrasonic contrasting agents are administered |
| 04/29/1993 | CA2121816A1 Substituted heterocycles as angiotensin ii antagonists |
| 04/29/1993 | CA2121815A1 Substituted aminopyrimidines as angiotensine ii antagonists |
| 04/29/1993 | CA2121814A1 Pyrimidocycloalkanes as angiotensin ii antagonists |
| 04/29/1993 | CA2121801A1 N-(mercaptoacyl)amino acids, methods of their preparation and therapeutic use, and pharmaceutical compositions containing them |
| 04/29/1993 | CA2120915A1 Tricyclic quinoxalinediones |
| 04/29/1993 | CA2118802A1 Imidazole derivatives and pharmaceutical compositions containing the same |
| 04/29/1993 | CA2099270A1 Quinoxaline derivatives with affinity for quisqualate-receptors |
| 04/28/1993 | EP0539281A1 New naphthamides, process for their preparation and their application in the therapeutical field |
| 04/28/1993 | EP0539117A1 Compounds useful as leukotriene antagonists |
| 04/28/1993 | EP0539086A2 Condensed pyrimidine derivatives and their use as angiotensine II antagonists |
| 04/28/1993 | EP0539066A1 Heterocyclic compounds useful as angiotensin II antagonists |
| 04/28/1993 | EP0539057A1 Benzimidazole phosphono-amino acids |
| 04/28/1993 | EP0538844A2 Tetrahydroprotoberberine quaternary ammonium compounds and the process for preparing thereof |
| 04/28/1993 | EP0538690A1 Arylquinoline substituted 1,4-dihydropyridine dicarboxylic derivatives, process for their preparation and their use as drugs |
| 04/28/1993 | EP0538404A1 Fibroblast growth factor receptors |
| 04/28/1993 | EP0538399A1 Cyclic cell adhesion modulation compounds |
| 04/28/1993 | CN1071426A Process for the preparation of novel acylals of imidazole-5-carboxylic acid derivatives |
| 04/28/1993 | CN1071333A Calcium receptor active molecules |
| 04/27/1993 | US5206384 Actinonin derivatives and pharmaceutically acceptable salts thereof |
| 04/27/1993 | US5206343 Oligopetides with cyclic proline-analogous amino acids |
| 04/27/1993 | US5206247 Spiro(4.5.)decane compounds |
| 04/27/1993 | US5206241 Labdanes and process for their preparation |
| 04/27/1993 | US5206239 Pyrroloazepine derivatives |
| 04/27/1993 | US5206222 Coadministering adenosine or an analog and lidocaine |
| 04/27/1993 | US5206008 Using androstene(diol or triol) |
| 04/27/1993 | US5206007 Useful in image diagnosis of heart diseases |
| 04/27/1993 | US5205290 Kits for imaging gastrointestinal disorders; anti-gas; biocompatible polymers, thickeners |
| 04/27/1993 | CA1316921C Cyclohexane derivative |
| 04/25/1993 | CA2081133A1 Pharmaceutical compounds |
| 04/24/1993 | CA2081147A1 Naphthamide derivatives, process for preparing them and their application in the therapeutic field |
| 04/24/1993 | CA2081049A1 Thiadiazinones |
| 04/23/1993 | CA2080864A1 Aryl-quinolyl-substituted 1,4-dihydropyridine-dicarboxylic acid derivatives, processes for their preparation and their use in drugs |
| 04/22/1993 | CA2080671A1 Benzothiazepine derivatives |
| 04/21/1993 | EP0538222A1 3-(N-Isopropyl-N-n-propylamino)-5-(N-isopropyl)carbamoylchroman as a selective 5-hydroxytryptamine receptor stimulant |
| 04/21/1993 | EP0538080A1 4-Aminomethylpiperidine derivatives, process for their preparation and their use in therapy |
| 04/21/1993 | EP0537949A1 Antiproliferative derivatives of 4H-naphtho 1,2-b pyran |
| 04/21/1993 | EP0537937A2 Substituted pyrazino 2,3-D pyrimidinones as angiotensin II antagonists |
| 04/21/1993 | EP0537201A1 Imidazolylbenzoyl substituted heterocycles |
| 04/21/1993 | EP0479871B1 Novel vitamin d analogues |
| 04/21/1993 | EP0387265B1 Use of 5-aminosalicyclic acid (5-asa) for the production of a pharmaceutical preparation for use in reperfusion treatment |
| 04/21/1993 | CN1071164A 含氮杂环化合物 Nitrogen-containing heterocyclic compounds |
| 04/20/1993 | US5204475 Treating cardiovascular disorders |
| 04/20/1993 | US5204464 Cardiotonic agents, vasodilators |
| 04/20/1993 | US5204364 N-imidazolyl- and n-imidazolylmethyl-derivatives of substituted bicyclic compounds |
| 04/20/1993 | US5204357 Enzyme inhibitors |
| 04/20/1993 | US5204351 Antiarteriosclerosis, anticholesterol agents |
| 04/20/1993 | US5204346 Pyrazolopyridine compounds |
| 04/20/1993 | US5204248 Process for preparing 2-halogeno-3-hydroxy-3-phenyl-propionic acid ester compounds |
| 04/20/1993 | CA1316630C Phosphinylcycloalkylcarbonyl and phosphinylcycloalkenylcarbonyl dipeptides |
| 04/20/1993 | CA1316535C Substituted 6-phenyldihydro-3(2h)-pyridazinones, a process for their preparation and pharmaceutical preparations containing these compounds |
| 04/15/1993 | WO1993007137A1 Pyridinol derivatives as medicaments |
| 04/15/1993 | WO1993007135A1 3-(n-isopropyl-n-n-propylamino)-5-(n-isopropyl)carbamoylchroman |
| 04/15/1993 | WO1993007124A1 Nitrogenous heterocyclic compound |
| 04/15/1993 | WO1993007114A1 Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs |
| 04/15/1993 | WO1993006863A1 Inhibition of vascular narrowing using anti-padgem antibodies |
| 04/15/1993 | WO1993006852A2 Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein |
| 04/15/1993 | WO1993006811A2 Vanadium compositions |
| 04/15/1993 | DE4134156A1 9-substituierte bicyclo(3.3.0)octan-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung 9-substituted bicyclo (3.3.0) octane derivatives, process for their production and their pharmaceutical use |
| 04/15/1993 | CA2120756A1 Pyridinol derivatives as medicaments |
| 04/15/1993 | CA2120338A1 Vanadium compositions |